sitagliptin (JANUVIA)

Worst Pills, Best Pills Newsletter Articles

Search results below include Worst Pills, Best Pills Newsletter Articles where your selected drug is a primary subject of discussion

Type 2 Diabetes Drugs Fail to Improve the Most Serious Long-Term Complications [hide all summaries]
(February 2010)
The article discusses why all of these 16 diabetes drugs carry a label stating: "There have been no clinical studies establishing conclusive evidence of macrovascular risk reduction [heart attacks, strokes, etc] with oral antidiabetic drug[s]." The article also explains why lifestlyle changes such as diet and exercise to prevent or even treat type II diabetes are not heavily promoted or usually reimbursed.
Update: Diabetes Drug JANUVIA (Sitagliptin) [hide all summaries]
(July 2008)
An increasing body of evidence documents both the risks and lack of evidence of clinical benefits associated with sitagliptin, and several reviews have cautioned against its use.
Sitagliptin (JANUVIA) for Type-2 Diabetes [hide all summaries]
(June 2007)
Worst Pills, Best Pills reviews side effects and long-term effects of type-2 diabetes drug sitagliptin (JANUVIA) in this article.